Cliff Asness's ELV Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 801.3K shares of Elevance Health, Inc. (ELV) worth $258.69 M, representing 0.17% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 548.0K shares. Largest reduction occurred in Q1 2016, reducing 1.0M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +1.98 M | New Buy | 1.98 M | $125.67 |
| Q1 2015 | -5,238 | Reduce 0.27% | 1.97 M | $154.41 |
| Q2 2015 | +338,964 | Add 17.20% | 2.31 M | $164.14 |
| Q3 2015 | +179,482 | Add 7.77% | 2.49 M | $140.00 |
| Q4 2015 | +473,066 | Add 19.00% | 2.96 M | $139.44 |
| Q1 2016 | -1.03 M | Reduce 34.61% | 1.94 M | $138.99 |
| Q2 2016 | +251,018 | Add 12.96% | 2.19 M | $131.34 |
| Q3 2016 | +445,988 | Add 20.38% | 2.63 M | $125.31 |
| Q4 2016 | +118,255 | Add 4.49% | 2.75 M | $143.77 |
| Q1 2017 | +315,756 | Add 11.47% | 3.07 M | $165.38 |
| Q2 2017 | +146 | Add 0.00% | 3.07 M | $188.13 |
| Q3 2017 | +137,122 | Add 4.47% | 3.21 M | $189.88 |
| Q4 2017 | +249,472 | Add 7.78% | 3.46 M | $225.01 |
| Q1 2018 | -327,075 | Reduce 9.47% | 3.13 M | $220.29 |
| Q2 2018 | -224,084 | Reduce 7.16% | 2.9 M | $238.67 |
| Q3 2018 | -376,365 | Reduce 12.96% | 2.53 M | $274.05 |
| Q4 2018 | +435,461 | Add 17.23% | 2.96 M | $262.63 |
| Q1 2019 | -349,974 | Reduce 11.81% | 2.61 M | $283.37 |
| Q2 2019 | -483,961 | Reduce 18.52% | 2.13 M | $277.74 |
| Q3 2019 | -878,239 | Reduce 41.25% | 1.25 M | $237.99 |
| Q4 2019 | -6,357 | Reduce 0.51% | 1.24 M | $302.03 |
| Q1 2020 | -175,743 | Reduce 14.12% | 1.07 M | $227.04 |
| Q2 2020 | -56,874 | Reduce 5.32% | 1.01 M | $257.09 |
| Q3 2020 | +136,285 | Add 13.47% | 1.15 M | $266.68 |
| Q4 2020 | -372,738 | Reduce 32.46% | 775,460 | $315.38 |
| Q1 2021 | -31,918 | Reduce 4.12% | 743,542 | $358.95 |
| Q2 2021 | -32,804 | Reduce 4.41% | 710,738 | $380.61 |
| Q3 2021 | +135,267 | Add 19.03% | 846,005 | $372.80 |
| Q4 2021 | -331,133 | Reduce 39.14% | 514,872 | $463.54 |
| Q1 2022 | -56,050 | Reduce 10.89% | 458,822 | $491.22 |
| Q2 2022 | -154,157 | Reduce 33.60% | 304,665 | $482.58 |
| Q3 2022 | +1,765 | Add 0.58% | 306,430 | $454.24 |
| Q4 2022 | -19,998 | Reduce 6.53% | 286,432 | $510.77 |
| Q1 2023 | -65,888 | Reduce 23.00% | 220,544 | $459.81 |
| Q2 2023 | +19,101 | Add 8.66% | 239,645 | $438.88 |
| Q3 2023 | +57,138 | Add 23.84% | 296,783 | $435.42 |
| Q4 2023 | -3,854 | Reduce 1.30% | 292,929 | $469.29 |
| Q1 2024 | -1,820 | Reduce 0.62% | 291,109 | $518.54 |
| Q2 2024 | -36,546 | Reduce 12.55% | 254,563 | $533.60 |
| Q3 2024 | +95,681 | Add 37.59% | 350,244 | $516.41 |
| Q4 2024 | +68,392 | Add 19.53% | 418,636 | $368.90 |
| Q1 2025 | +224,536 | Add 53.64% | 643,172 | $434.96 |
| Q2 2025 | -389,854 | Reduce 60.61% | 253,318 | $383.31 |
| Q3 2025 | +547,950 | Add 216.31% | 801,268 | $322.85 |
Cliff Asness's Elevance Health Investment FAQs
Cliff Asness first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 1,976,399 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Elevance Health, Inc. (ELV) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 1,976,399 shares worth $248.37 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 801,268 shares of Elevance Health, Inc. (ELV), valued at approximately $258.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.17% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Elevance Health, Inc. (ELV) was 3,455,124 shares, as reported at the end of Q4 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.